BridgeBio Oncology Therapeutics, Inc. Increase (Decrease) in Due to Related Parties, Current
BridgeBio Oncology Therapeutics, Inc. (BBOT) reported Increase (Decrease) in Due to Related Parties, Current of $38.75 thousand for the 6-month period ending 2025-06-30, per its 10-Q filed 2025-08-01.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInDueToRelatedPartiesCurrent · last filed 2025-08-01
- BridgeBio Oncology Therapeutics, Inc. increase (decrease) in due to related parties, current for the quarter ending 2025-06-30 was $19.37K.
- BridgeBio Oncology Therapeutics, Inc. increase (decrease) in due to related parties, current for the quarter ending 2025-03-31 was $19.37K.
- BridgeBio Oncology Therapeutics, Inc. increase (decrease) in due to related parties, current for fiscal 2024 was $67.81K.
| Period end | Increase (Decrease) in Due to Related Parties, Current 3 month | Increase (Decrease) in Due to Related Parties, Current 6 month | Increase (Decrease) in Due to Related Parties, Current 12 month |
|---|---|---|---|
| 2025-06-30 | $19.37K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-01 | $38.75K 10-Q · filed 2025-08-01 | |
| 2025-03-31 | $19.37K 10-Q · filed 2025-05-15 | ||
| 2024-12-31 | $67.81K 10-K · filed 2025-03-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Evommune, Inc. (EVMN) | United States | $0.320B | -5.10 |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |
| ABEONA THERAPEUTICS INC. (ABEO) | United States | $0.312B | -5.63 |
| GT Biopharma, Inc. (GTBP) | United States | $0.309B | -4.58 |
| BioAge Labs, Inc. (BIOA) | United States | $0.333B | -11.88 |
| Benitec Biopharma Inc. (BNTC) | United States | $0.337B | -10.08 |
| Vanda Pharmaceuticals Inc. (VNDA) | United States | $0.302B | -1.35 |
| STANDARD BIOTOOLS INC. (LAB) | United States | $0.297B | 3.80 |
| Larimar Therapeutics, Inc. (LRMR) | United States | $0.344B | -1.83 |
| ROCKET PHARMACEUTICALS, INC. (RCKT) | United States | $0.296B | -21.78 |